Abiopharma

Clinical trial NCT05675449 updates: 1. primary completion date: 2025-07-07 → 2026-03-11 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT02732184 updates: 1. phase: PHASE2 → PHASE1 2. start date: 2016-08-01 → 2016-08-15 3. completion date: 2017-12-01 → 2017-11-01 4. primary completion date: 2017-12-01 → 2017-11-01 5. enrollment: 29 → 21 participants 6. intervention model: SINGLE_GROUP → SEQUENTIAL 7. collaborators added: Aeglea Biotherapeutics (Study sponsor)

Clinical trial NCT06393920 updates: 1. completion date: 2027-07-01 → 2028-07-31 2. primary completion date: 2026-07-01 → 2026-10-31

Clinical trial NCT06016738 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-09-30 → 2028-02-29 3. primary completion date: 2026-06-30 → 2026-10-31

Clinical trial NCT06712316 updates: 1. completion date: 2030-03-01 → 2031-12-01 2. primary completion date: 2029-02-01 → 2029-01-01 3. enrollment: 1260 → 1580 participants

Clinical trial NCT06465485 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-29 → 2026-05-13 3. primary completion date: 2026-05-29 → 2026-05-13

Clinical trial NCT06526793: primary completion date: 2027-11-24 → 2028-04-21.

Clinical trial NCT05733715 updates: 1. completion date: 2028-01-01 → 2028-12-01 2. primary completion date: 2026-06-01 → 2028-04-01

Clinical trial NCT06154174 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-11-01 → 2027-01-01 3. primary completion date: 2026-11-01 → 2027-01-01

Clinical trial NCT07154290 updates: 1. completion date: 2030-06-24 → 2030-06-10 2. primary completion date: 2030-06-24 → 2030-06-10